- testing |
₹22,900.65
(-4.34)
(-0.01%)
03 Dec , 2025 | 03:04 PM
Open
₹22,949.3
Prev. Close
₹22,905
Market Cap.
₹17,77,352.83
Div Yield
0.67
PE
33.87
PB
33.87
₹22,726.5
₹23,005.3
Performance
One Week (%)
1.39
One Month (%)
2.06
One Year (%)
2.02
YTD (%)
10.26
Company Name | CMP | High | Low | Volume |
|---|---|---|---|---|
Abbott India Ltd | 28,975 | 29,720 | 28,820 | 10,243 |
Cipla Ltd | 1,506.1 | 1,522.8 | 1,495.1 | 8,63,236 |
J B Chemicals & Pharmaceuticals Ltd | 1,764.4 | 1,788.3 | 1,758 | 56,660 |
Dr Reddys Laboratories Ltd | 1,280.1 | 1,293 | 1,269.2 | 46,19,088 |
Lupin Ltd | 2,077.4 | 2,102.8 | 2,053.6 | 8,87,220 |
Torrent Pharmaceuticals Ltd | 3,720.1 | 3,770.9 | 3,705.1 | 1,38,915 |
Ipca Laboratories Ltd | 1,447.2 | 1,454.7 | 1,415.3 | 1,27,687 |
Sun Pharmaceutical Industries Ltd | 1,807.9 | 1,816 | 1,782.5 | 17,78,314 |
Aurobindo Pharma Ltd | 1,207.8 | 1,214 | 1,196.4 | 6,12,822 |
Wockhardt Ltd | 1,417.5 | 1,479.6 | 1,404.6 | 23,50,069 |
Ajanta Pharma Ltd | 2,604.3 | 2,624.7 | 2,550.1 | 70,697 |
Gland Pharma Ltd | 1,777.9 | 1,815 | 1,747 | 1,02,592 |
Biocon Ltd | 409.8 | 412.5 | 400.05 | 1,01,26,337 |
Alkem Laboratories Ltd | 5,646 | 5,687 | 5,603 | 30,383 |
Glenmark Pharmaceuticals Ltd | 1,965 | 1,992.9 | 1,954.9 | 7,62,064 |
Zydus Lifesciences Ltd | 933.35 | 947 | 930.5 | 10,09,278 |
Divis Laboratories Ltd | 6,445.5 | 6,455 | 6,342.5 | 2,23,431 |
Mankind Pharma Ltd | 2,202.9 | 2,228 | 2,178 | 9,21,475 |
Laurus Labs Ltd | 1,014 | 1,026.9 | 1,007.8 | 7,40,460 |
Piramal Pharma Ltd | 182.01 | 187.7 | 181.29 | 22,33,203 |
Sector-wise, the Metal index emerged as a standout performer, witnessing a substantial 4% surge.
1 Mar 2024|03:40 PM
This revision applies to all Bank Nifty contracts, including weekly, monthly, and quarterly, shifting their expiry to Wednesdays
1 Mar 2024|09:57 AM
Bharat Highways InvIT, which boasts a portfolio of seven road assets, launched the IPO with the goal of raising ₹2,500 Crore
29 Feb 2024|11:42 AM
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
